Consonance Capital Management as of June 30, 2014
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 24 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals (ENTA) | 9.9 | $67M | 1.5M | 43.07 | |
| Orthofix International Nv Com Stk | 7.9 | $53M | 1.5M | 36.25 | |
| Taro Pharmaceutical Industries (TARO) | 7.9 | $53M | 378k | 140.24 | |
| Cardiovascular Systems | 7.5 | $51M | 1.6M | 31.16 | |
| United Therapeutics Corporation (UTHR) | 5.6 | $38M | 427k | 88.49 | |
| WuXi PharmaTech | 5.6 | $38M | 1.1M | 32.86 | |
| Insys Therapeutics | 5.5 | $37M | 1.2M | 31.23 | |
| Abbvie (ABBV) | 5.1 | $35M | 611k | 56.44 | |
| Hyperion Therapeutics | 5.0 | $33M | 1.3M | 26.10 | |
| BioScrip | 4.9 | $33M | 4.0M | 8.34 | |
| Osiris Therapeutics | 4.6 | $31M | 2.0M | 15.62 | |
| Pernix Therapeutics Holdings | 4.0 | $27M | 3.0M | 8.98 | |
| IPC The Hospitalist Company | 3.8 | $25M | 573k | 44.22 | |
| HMS Holdings | 3.3 | $22M | 1.1M | 20.41 | |
| Myriad Genetics (MYGN) | 2.9 | $20M | 508k | 38.92 | |
| Akorn | 2.5 | $17M | 512k | 33.25 | |
| Derma Sciences | 2.5 | $17M | 1.5M | 11.56 | |
| Supernus Pharmaceuticals (SUPN) | 2.4 | $16M | 1.4M | 10.95 | |
| Anacor Pharmaceuticals In | 2.3 | $16M | 888k | 17.73 | |
| Healthways | 2.2 | $15M | 850k | 17.54 | |
| Biosante Pharmaceuticals (ANIP) | 1.8 | $12M | 355k | 34.44 | |
| Flamel Technologies | 1.4 | $9.5M | 630k | 15.00 | |
| Adma Biologics (ADMA) | 1.0 | $6.5M | 667k | 9.75 | |
| Furiex Pharmaceuticals | 0.2 | $1.4M | 13k | 106.18 |
